A multivariate Cox regression analysis indicated that the significant independent prognostic factors for pancreatic cancer were treatments [HR, 0.62; 95% confidence interval (CI), 0.41–0.95; P = 0.03], stages (HR, 1.95; 95% CI, 1.29–2.96; P < 0.01), and EphA2-NF (HR, 1.97; 95% CI, 1.52–2.56; P < 0.01; Table 2). The gene discussed is EPHA2; the disease is pancreatic neoplasm.